Clinical Trial Update: A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase Ib study of HS-10370 in combination with other anti-cancer therapies for advanced solid tumors, including colorectal cancer and non-small cell lung cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• HS-10370

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Advanced Solid Tumors, Colorectal Cancer | Phase 1 | Status: NOT_YET_RECRUITING